Literature DB >> 14860396

Fatty liver following aureomycin and terramycin therapy in chronic hepatic disease.

V M SBOROV, D A SUTHERLAND.   

Abstract

Entities:  

Keywords:  AUREOMYCIN; LIVER, EFFECTS OF DRUGS ON; TERRAMYCIN

Mesh:

Substances:

Year:  1951        PMID: 14860396

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  9 in total

1.  TETRACYCLINE AND FATTY LIVER.

Authors:  L D WRUBLE; A J CUMMINS
Journal:  Am J Dig Dis       Date:  1965-08

2.  Persistence of antibiotics in blood of patients with acute renal failure. I. Tetracycline and chlortetracycline.

Authors:  C M KUNIN; S B REES; J P MERRILL; M FINLAND
Journal:  J Clin Invest       Date:  1959-09       Impact factor: 14.808

3.  Strangulation obstruction; the effect of pre- and post- operative antibacterial agents.

Authors:  I COHN; A GELB; H R HAWTHORNE
Journal:  Ann Surg       Date:  1953-11       Impact factor: 12.969

4.  Polyarteritis nodosa, with an unusual ocular presentation.

Authors:  G M Maclure
Journal:  Br J Ophthalmol       Date:  1968-02       Impact factor: 4.638

5.  The effect of tetracycline on human liver cells in culture.

Authors:  A J Zuckerman; S F Baker; L J Dunkley
Journal:  Br J Exp Pathol       Date:  1968-02

6.  Drug effects on the liver: a tabular compilation of drugs and drug-related hepatic diseases.

Authors:  J Ludwig
Journal:  Dig Dis Sci       Date:  1979-10       Impact factor: 3.199

7.  Experimental studies on the hepatic effects of tetracycline.

Authors:  S E Miller; R N MacSween; A C Glen; K Tribedi; F M Moore
Journal:  Br J Exp Pathol       Date:  1967-02

Review 8.  Drug effects on the liver. An updated tabular compilation of drugs and drug-related hepatic diseases.

Authors:  J Ludwig; R Axelsen
Journal:  Dig Dis Sci       Date:  1983-07       Impact factor: 3.199

9.  The role of intestinal bacteria in the development of dietary cirrhosis in rats.

Authors:  A M RUTENBURG; E SONNENBLICK; I KOVEN; H A APRAHAMIAN; L REINER; J FINE
Journal:  J Exp Med       Date:  1957-07-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.